NEW YORK (
CHANGE IN RATINGS
Agree Realty Corporation
upgraded to buy at TheStreet Ratings.
rated new Hold at Stifel Nicolaus. Valuation call.
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $41 price target.
downgraded at Global Hunter from Buy to Accumulate, Global Hunter said. $47 price target. Company lacks near-term catalysts.
downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Valuation call, based on a $189 price target.
Bank of Hawaii
downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.
downgraded at Citi to Neutral, Citigroup said. Stock is not yet pricing in lower earnings potential.
upgraded at BMO from Market Perform to Outperform, BMO Capital said. $30 price target. Company is leveraged to multiple healthcare growth trends.
downgraded at Baird from Neutral to Underperform, Robert Baird said. Valuation call, based on a $34 price target.
(DOV - Get Report)
rated new Underweight at Morgan Stanley. Coverage of DOV was started with an Equal-weight rating, Morgan Stanley said. $64 price target. Company is the most cyclical stock in its industry.
(ED - Get Report)
downgraded at Citi to Neutral, Citigroup said. Valuation call.
Corporate Exec. Board
downgraded at BofA/Merrill to Underperform, Bank of America/Merrill Lynch said. $34 price target. Company has limited visibility and high exposure to Europe.
downgraded at Citi to Neutral. Company will be hurt by lower forward energy prices.
rated new Buy at Keybanc. FOSL was initiated with a Buy rating, Keybanc said. $105 price target. Company has minimal competition and can continue to grow in Asia.
(GE - Get Report)
rated new Overweight at Morgan Stanley. $20 price target. Company has limited downside risk and pays a 4% dividend. Also see:
General Electric Gets Overweight Nod by Morgan Stanley
(GOOG - Get Report)
downgraded at Benchmark from Buy to Hold, Benchmark said. $700 price target. Checks suggest that business has slowed down in Europe.
(HON - Get Report)
rated new Overweight at Morgan Stanley. $62 price target. Company is the best way to play growth in energy efficiency.
rated new Buy at ThinkEquity. $550 price target. Da Vinci can continue to drive solid growth.